CN Patent

CN104327119A — 磷酸泰地唑胺的制备方法

Assigned to Suzhou Miracpharma Technology Co Ltd · Expires 2015-02-04 · 11y expired

What this patent protects

本发明揭示了一种磷酸泰地唑胺(tedizolid phosphate，I)的制备方法，其制备步骤包括：通过式II化合物与式III化合物进行偶联反应生成磷酸泰地唑胺(I)，该制备方法原料易得，工艺简洁，经济环保，适合工业化生产。

USPTO Abstract

本发明揭示了一种磷酸泰地唑胺(tedizolid phosphate，I)的制备方法，其制备步骤包括：通过式II化合物与式III化合物进行偶联反应生成磷酸泰地唑胺(I)，该制备方法原料易得，工艺简洁，经济环保，适合工业化生产。

Drugs covered by this patent

Patent Metadata

Patent number
CN104327119A
Jurisdiction
CN
Classification
—
Expires
2015-02-04
Drug substance claim
No
Drug product claim
No
Assignee
Suzhou Miracpharma Technology Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.